Intravascular Ultrasound Findings in Patients With Very Late Stent Thrombosis After Either Drug-Eluting or Bare-Metal Stent Implantation

被引:130
|
作者
Lee, Cheol Whan
Kang, Su-Jin
Park, Duk-Woo
Lee, Seung-Hwan
Kim, Young-Hak
Kim, Jae-Joong
Park, Seong-Wook
Mintz, Gary S. [2 ]
Park, Seung-Jung [1 ]
机构
[1] Univ Ulsan, Asan Med Ctr, Div Cardiol, Dept Med, Seoul 138736, South Korea
[2] Cardiovasc Res Fdn, New York, NY USA
关键词
imaging; stent; thrombosis; MALAPPOSITION; APPOSITION; EFFICACY; SAFETY; RISK;
D O I
10.1016/j.jacc.2009.10.077
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives This study compared intravascular ultrasound (IVUS) findings at drug-eluting stent (DES) and bare-metal stent (BMS) sites in patients with very late stent thrombosis (VLST). Background VLST is being increasingly identified since the introduction of DES. VLST can also develop after BMS placement, but the underlying mechanisms remain unknown. Methods A total of 30 consecutive VLST patients with acute myocardial infarction (DES, n = 23; BMS, n = 7) were enrolled. Patients underwent IVUS examination before coronary angioplasty. Results The baseline characteristics were similar for the 2 groups, with the exception of reference vessel size, lesion length, stent length, minimal lumen diameter, and diameter stenosis after the procedure. Overall, VLST occurred at a mean 50.8 +/- 36.2 months after the index procedure, and occurred earlier after DES than BMS (33.2 +/- 12.5 months vs. 108.4 +/- 26.5 months, p < 0.001). IVUS variables were generally similar for the 2 groups. However, plaque burden at the distal reference segment, stent, and neointimal area of the in-stent segment were smaller in the DES group. Stent malapposition was observed in 73.9% of DES patients, but in no BMS patients (p = 0.001). Disease progression with neointimal rupture within the stent was observed in 10 DES patients (43.5%) and 7 BMS patients (100%; p = 0.010). Conclusions Stent malapposition was unique to DES-related VLST, whereas disease progression with neointimal rupture was more common in BMS patients. These findings suggest that different biological mechanisms underlie VLST development depending upon the stent type. (J Am Coll Cardiol 2010;55:1936-42) (C) 2010 by the American College of Cardiology Foundation
引用
收藏
页码:1936 / 1942
页数:7
相关论文
共 50 条
  • [41] Atherosclerotic plaque behind the stent changes after bare-metal and drug-eluting stent implantation in humans: Implications for late stent failure?
    Andreou, Ioannis
    Takahashi, Saeko
    Tsuda, Masaya
    Shishido, Koki
    Antoniadis, Antonios P.
    Papafaklis, Michail I.
    Mizuno, Shingo
    Coskun, Ahmet U.
    Saito, Shigeru
    Feldman, Charles L.
    Edelman, Elazer R.
    Stone, Peter H.
    ATHEROSCLEROSIS, 2016, 252 : 9 - 14
  • [42] The risk of late stent malapposition is higher after drug-eluting stent compared to bare-metal stent implantation and is associated with late stent thrombosis: meta-analysis and systematic review
    Hassan, A. K. M.
    Bergheanu, S. C.
    Stijnen, T.
    Van der Hoeven, B. L.
    Schalij, M. J.
    Jukema, J. W.
    EUROPEAN HEART JOURNAL, 2008, 29 : 777 - 777
  • [43] The conundrum of late and very late stent thrombosis following drug-eluting stent implantation
    Garg, Pallav
    Mauri, Laura
    CURRENT OPINION IN CARDIOLOGY, 2007, 22 (06) : 565 - 571
  • [44] Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal Stent coronary interventions
    Jensen, Lisette Okkels
    Maeng, Michael
    Kaltoft, Anne
    Thayssen, Per
    Hansen, Hans Henrik Tilsted
    Bottcher, Morten
    Lassen, Jens Flensted
    Krussel, Lars Romer
    Rasmussen, Klaus
    Hansen, Knud Noerregaard
    Pedersen, Lars
    Johnsen, Soeren Paaske
    Soerensen, Henrik Toft
    Thuesen, Leif
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (05) : 463 - 470
  • [45] The risk of definitive stent thrombosis is increased after “off-label” stent implantation irrespective of drug-eluting stent or bare-metal stent use
    Rainer Hoffmann
    Helene Klinker
    Umar Adamu
    Malte Kelm
    Rüdiger Blindt
    Clinical Research in Cardiology, 2009, 98 : 549 - 554
  • [46] The risk of definitive stent thrombosis is increased after "off-label" stent implantation irrespective of drug-eluting stent or bare-metal stent use
    Hoffmann, Rainer
    Klinker, Helene
    Adamu, Umar
    Kelm, Malte
    Blindt, Ruediger
    CLINICAL RESEARCH IN CARDIOLOGY, 2009, 98 (09) : 549 - 554
  • [47] Clinical Profile and Outcomes of Patients with Very Late Thrombosis after Bare-Metal Stent Implantation
    Gomez-Blazquez, I
    Fernandez-Barbeira, S.
    Bastos-Fernandez, G.
    de Miguel-Castro, A. A.
    Jimenez-Diaz, V. A.
    Ortiz-Saez, A.
    Baz-Alonso, J. A.
    Iniguez-Romo, A.
    CORONARY ARTERY DISEASE 2013, 2013, : 311 - 313
  • [48] CLINICAL PROFILE AND OUTCOMES OF PATIENTS WITH VERY LATE THROMBOSIS AFTER BARE-METAL STENT IMPLANTATION
    Gomez Blazquez, I.
    Fernandez Barbeira, S.
    Bastos Fernandez, G.
    De Miguel Castro, A. A.
    Jimenez Diaz, V. A.
    Ortiz Saez, A.
    Baz Alonso, J. A.
    Iniguez Romo, A.
    CARDIOLOGY, 2013, 126 : 110 - 110
  • [49] A Case of Very Late Stent Thrombosis 11 Years After Drug-Eluting Stent Implantation
    Vijayvergiya, Rajesh
    Kumar, Basant
    Kasinadhuni, Ganesh
    Mohanty, Soumitra
    JOURNAL OF INVASIVE CARDIOLOGY, 2019, 31 (08): : E261 - E262